ALBI, albumin–bilirubin; CRP, C-reactive protein; HCC, hepatocellular carcinoma; LS, liver stiffness; MELD-Na, model for end-stage liver disease sodium; NLR, neutrophil-to-lymphocyte ratio; PT, prothrombin activity; TC, total cholesterol. This evidence concerns the gene F2 and hepatocellular carcinoma.